Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

New Survey Reveals First Impressions May Not Always be Rosy for People With the Widespread Skin Condition Rosacea

Survey Finds that Women with Rosacea Symptoms are More Likely to be Perceived by Others as Unhealthy, Insecure, Less Intelligent


News provided by

National Rosacea Society; Galderma Laboratories, L.P.

Apr 14, 2010, 09:30 ET

Share this article

Share toX

Share this article

Share toX

BARRINGTON, Ill., April 14 /PRNewswire/ -- From job interviews to first dates, creating a positive and lasting first impression often goes a long way. For women with symptoms of the common skin condition rosacea, just how much does the appearance of their skin affect how people perceive them?  A unique digital perception survey, developed in partnership with the National Rosacea Society (NRS) and Galderma Laboratories, contrasted images of women with signs of mild to moderate papular/pustular rosacea (an inflammatory skin condition characterized by redness, bumps and blemishes) and images of women with clear skin. The survey was taken by 1,009 members of the general population and 502 women with rosacea, equaling 1,511 survey respondents in total. In the survey, adults were asked to give their opinions of women based solely on photographs of their faces: half of the photographs featured the women with clear skin and half of the photographs were digitally enhanced to simulate rosacea symptoms on their faces. The survey found that based on first impressions of the images, when it comes to attributes such as confidence, attitude and intelligence, women with rosacea symptoms were consistently ranked differently than their clear-skinned counterparts.

The results, which are part of the national educational campaign Rosacea SKINsights sponsored by Galderma Laboratories, also reveal the lengths that women with rosacea would go to if they could get rid of their rosacea forever, and highlight the low awareness and complicated diagnosis path for this common condition. On average, women with rosacea waited at least seven months before receiving a correct diagnosis, and only half of respondents had ever heard of the condition upon the time of diagnosis. This reveals the high level of misunderstanding and confusion that surrounds rosacea, a chronic disorder primarily of the facial skin, often characterized by flare-ups and remissions.

Rosacea's Impact on Health and Personality Traits

According to survey results, women with rosacea are more likely than women without the skin condition to be perceived by others among the general population as looking unhealthy (11% vs. 2%) and tired (43% vs. 32%).  Survey respondents also formed personality judgments about women with pustular/papular rosacea, describing them as more likely to be insecure (33% vs. 13%) and shy (34% vs. 18%) than their counterparts. In contrast, women with clear skin were more commonly perceived as having positive social characteristics such as confidence (49% vs. 27%) and happiness (54% vs. 36%).

The appearance of rosacea also influenced survey respondents' perceptions of important personal characteristics that could negatively impact how rosacea sufferers are viewed in the workplace. Compared to women with clear skin, women with rosacea symptoms were considered to be less intelligent (36% vs. 43%) and not as successful (18% vs. 32%).Women with rosacea symptoms were also perceived to be more stressed (40% vs. 23%) and more likely to have entry level positions (22% vs. 11%).

Women with Rosacea Perceived as Less Lucky in Love

Career and personality traits were not the only perceived source of disparity between women with rosacea and those without – survey results show that Americans thought that women with rosacea were less lucky in love, including less likely to be in a relationship (64% vs. 81%) and less likely to go on weekend dates (14% vs. 22%).One in five women (19%) with rosacea surveyed would even rather have clear and smooth skin than an eternally fulfilling love life.

The Lengths Rosacea Sufferers Would Go To for Clear Skin

The women with rosacea who participated in the survey judged rosacea as the negative focal point of their faces. In order to achieve clear skin, women with rosacea said they would be willing to forgo wearing make-up (33%), exercising (22%) and watching television for one year (21%).They would also give up eating chocolate (44%) and dating (25%) for one year if that meant that they did not have to deal with their skin condition on a daily basis. Lastly, despite today's challenging economic environment, women with rosacea would pay an average of nearly $6,000 and 14 percent would reduce their income by 10 percent for five years, to have clear and smooth skin forever. Nine percent would choose clear skin over being financially well-off for life.

"The survey results confirm that rosacea can have a strong impact on people professionally, socially and romantically," said Samuel Huff, Executive Director of the National Rosacea Society. "The National Rosacea Society urges people to educate themselves about this widespread, yet often misunderstood disease, and encourages anyone who thinks they may have rosacea to see a dermatologist to receive a timely diagnosis and appropriate therapy."

"Unfortunately, many people with rosacea do not recognize the symptoms and often mistake their rosacea for another skin condition; therefore they are not taking advantage of the effective medical solutions that are available," said Dr. Doris Day, dermatologist and clinical assistant professor of Dermatology at the New York University Langone Medical Center. "Without proper treatment, rosacea flare-ups can progressively worsen so it is critical to visit a doctor for an accurate diagnosis. Your skin's appearance can be a prominent factor in how you perceive yourself and how others perceive you, so it is very important that everyone takes control of their skin and puts their best face forward."

Rosacea Awareness Month Resources

The National Rosacea Society annually designates April as Rosacea Awareness Month to increase recognition of the signs and symptoms of rosacea and to help people understand that rosacea is a medical condition that can get progressively worse without treatment. People who suspect that they may have rosacea or those who would like to learn more about this common condition are encouraged to learn the facts on rosacea at www.rosaceafacts.com, which is a site dedicated to arming people with the facts on rosacea, including symptoms and triggers, and providing them with additional resources about the condition.

About Rosacea

Rosacea is a chronic disorder primarily of the facial skin, often characterized by flare-ups and remissions. It typically begins any time after age 30 as a redness on the cheeks, nose, chin or forehead that may come and go. Over time, the redness tends to become ruddier and more persistent, and visible blood vessels may appear. Bumps and pimples are a symptom, and in severe cases the nose may grow swollen and bumpy from excess tissue. Although rosacea can affect all segments of the population, individuals with fair skin who tend to flush or blush easily are believed to be at greatest risk. While there is no cure for rosacea and the cause is unknown, medical therapy is available to manage its signs and symptoms. Individuals who suspect they may have rosacea are urged to see a dermatologist or other knowledgeable physician for diagnosis and appropriate treatment.

About the National Rosacea Society

The National Rosacea Society (NRS) is the world's largest organization dedicated to improving the lives of the estimated 16 million Americans who suffer from this widespread but poorly understood disorder. Through education and advocacy, its mission is threefold: to raise awareness of rosacea, to provide public health information on the disorder, and to encourage and support medical research that may lead to improvements in its management, prevention and potential cure. Since 1992, the NRS has made a difference in the way rosacea patients are treated and the way this widespread disorder is perceived and understood. Information and materials are available on the society's Web site at www.rosacea.org.

About Galderma

Galderma, created in 1981 as a joint venture between Nestle and L'Oreal, is a fully-integrated specialty pharmaceutical company dedicated exclusively to the field of dermatology. The Company is committed to improving the health of skin with an extensive line of products across the world that treat a range of dermatological conditions. With a research and development center in Sophia Antipolis, France, Galderma has one of the largest R&D facilities dedicated exclusively to dermatology. Leading worldwide dermatology brands include Differin®, MetroGel® 1%/Rozex®, Clobex®, Tri-Luma®, Loceryl®, Vectical® Ointment, Epiduo™ Gel and Cetaphil®. For more information on Galderma, visit www.galdermausa.com.

About the National Rosacea First Impressions Survey

Kelton Research conducted two separate national online surveys, one with a sample of N=1,009 nationally representative adults age 18+ and one with a sample of N=502 women ages 18+ who had been diagnosed with rosacea. Both groups took the survey which was fielded between December 10th and December 28th, 2009. Quotas were set to ensure reliable and accurate representation of each audience. Each respondent answered questions about several pictures of people with or without rosacea. The overall margin of error for the general population in this study is +/-3.1 percentage points at the 95% confidence level. for the women with rosacea it is +/- 4.4 percentage points at the 95% confidence level. Margins for subgroups are slightly higher.

The survey was sponsored by Galderma Laboratories and developed in partnership with the National Rosacea Society.

SOURCE National Rosacea Society; Galderma Laboratories, L.P.

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.